NASDAQ: QNME
Quanome Technologies Inc Stock

$0.32-0.05 (-13.51%)
Updated Nov 9, 2026
QNME Price
$0.32
Fair Value Price
-$0.25
Market Cap
$11.05M
52 Week Low
$0.25
52 Week High
$1.40
P/E
-0.89x
P/B
1.58x
P/S
1.91x
PEG
N/A
Dividend Yield
N/A
Revenue
$5.85M
Earnings
-$9.48M
Gross Margin
56.7%
Operating Margin
-157.98%
Profit Margin
-162.1%
Debt to Equity
0.66
Operating Cash Flow
-$5M
Beta
0.93
Next Earnings
Nov 18, 2026
Ex-Dividend
N/A
Next Dividend
N/A

QNME Overview

Following a name change from Lakeside Holding Limited in August 2026, the company shifted its strategic focus to technologies, applications, and partnerships at the intersection of quantum computing, artificial intelligence, and advanced simulation. The company's initial areas of interest include quantum and AI-enabled decision systems, molecular and materials simulation, and pharmaceutical and healthcare applications. Quanome intends to develop a broad portfolio of quantum-enabled technologies, software applications, and analytical systems.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine QNME's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Logistic

Industry Rating
C
QNME
Ranked
Unranked of 19

Top Ranked Stocks in Industry

View Top Logistic Stocks

Be the first to know about important QNME news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how QNME scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

QNME ($0.32) is overvalued by 230.1% relative to our estimate of its Fair Value price of -$0.25 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
QNME ($0.32) is not significantly undervalued (230.1%) relative to our estimate of its Fair Value price of -$0.25 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
QNME is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more QNME due diligence checks available for Premium users.

Valuation

QNME fair value

Fair Value of QNME stock based on Discounted Cash Flow (DCF)

Price
$0.32
Fair Value
-$0.25
Undervalued by
229.70%
QNME ($0.32) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
QNME ($0.32) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
QNME is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

QNME price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.89x
Industry
15.05x
Market
41.55x

QNME price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.58x
Industry
3.88x
QNME is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

QNME's financial health

Profit margin

Revenue
$742.3k
Net Income
-$6.7M
Profit Margin
-900.7%
QNME's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
QNME's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$11.7M
Liabilities
$4.6M
Debt to equity
0.66
QNME's short-term assets ($11.02M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
QNME's short-term assets ($11.02M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
QNME's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
QNME's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$142.6k
Investing
-$654.9k
Financing
$70.3k
QNME's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

QNME vs Logistic Stocks

TickerZen RatingMarket Cap1d %P/EP/B
QNME–$11.05M-13.94%-0.89x1.58x
JYD–$12.35M-3.95%-0.49x0.66x
SLGB–$8.17M-4.52%-2.88x0.41x
ELOG–$7.97M+0.32%-6.21x0.52x
BTOC–$5.25M+1.09%-0.25x0.66x

Quanome Technologies Stock FAQ

What is Quanome Technologies's quote symbol?

(NASDAQ: QNME) Quanome Technologies trades on the NASDAQ under the ticker symbol QNME. Quanome Technologies stock quotes can also be displayed as NASDAQ: QNME.

If you're new to stock investing, here's how to buy Quanome Technologies stock.

What is the 52 week high and low for Quanome Technologies (NASDAQ: QNME)?

(NASDAQ: QNME) Quanome Technologies's 52-week high was $1.40, and its 52-week low was $0.25. It is currently -77.07% from its 52-week high and 26.38% from its 52-week low.

How much is Quanome Technologies stock worth today?

(NASDAQ: QNME) Quanome Technologies currently has 34,427,559 outstanding shares. With Quanome Technologies stock trading at $0.32 per share, the total value of Quanome Technologies stock (market capitalization) is $11.05M.

Quanome Technologies stock was originally listed at a price of $4.01 in Jun 28, 2024. If you had invested in Quanome Technologies stock at $4.01, your return over the last 2 years would have been -92%, for an annualized return of -71.71% (not including any dividends or dividend reinvestments).

How much is Quanome Technologies's stock price per share?

(NASDAQ: QNME) Quanome Technologies stock price per share is $0.32 today (as of Nov 9, 2026).

What is Quanome Technologies's Market Cap?

(NASDAQ: QNME) Quanome Technologies's market cap is $11.05M, as of Nov 10, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Quanome Technologies's market cap is calculated by multiplying QNME's current stock price of $0.32 by QNME's total outstanding shares of 34,427,559.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.